Veterinary Medicines

Rapidexon 2 mg/ml Solution injectable

Authorised
  • Dexamethasone sodium phosphate
Download as PDF

Product identification

Medicine name:
Rapidexon 2 mg/ml Solution injectable
Rapidexon 2 mg/ml Injektionslösung
Active substance:
  • Dexamethasone sodium phosphate
Target species:
  • Cattle
  • Pig
  • Horse
  • Dog
  • Cat
Route of administration:
  • Intraarterial use
  • Intramuscular use
  • Intravenous use

Product details

Active substance and strength:
  • Dexamethasone sodium phosphate
    2.63
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intraarterial use
    • Cattle
      • Meat and offal
        8
        day
      • Milk
        72
        hour
    • Pig
      • Meat and offal
        2
        day
    • Horse
      • Meat and offal
        8
        day
  • Intramuscular use
    • Cattle
      • Meat and offal
        8
        day
      • Milk
        72
        hour
    • Pig
      • Meat and offal
        2
        day
    • Horse
      • Meat and offal
        8
        day
  • Intravenous use
    • Cattle
      • Meat and offal
        8
        day
      • Milk
        72
        hour
    • Pig
      • Meat and offal
        2
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QH02AB02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Luxembourg
Package description:
  • 100 ml vial glass type I uncoloured with bromobutyl rubber stopper type I secured with aluminium cap
  • 25 ml vial glass type I uncoloured with bromobutyl rubber stopper type I secured with aluminium cap
  • 50 ml vial glass type I uncoloured with bromobutyl rubber stopper type I secured with aluminium cap

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Dechra Regulatory B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Eurovet Animal Health B.V.
Responsible authority:
  • Ministere De La Sante Division De La Pharmacie Et Des Medicaments
Authorisation number:
  • V 914/98/02/0586
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 30/06/2023
Download